Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Journal of Hypertension|July 1, 2010
Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patientsStephanie Madec, Massimo Chiarugi, Eleonora Santini, et al.
Frontiers in Endocrinology|November 22, 2018
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLDMarta Seghieri, Alexander S Christensen, Andreas Andersen, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2015
Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by MetabolomicsAnna Solini, Maria Laura Manca, Giuseppe Penno, et al.
Environmental Research|October 16, 2020
SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: A randomized clinical trialAlessandro Mengozzi, Fabrizia Carli, Letizia Guiducci, et al.
Atherosclerosis|October 8, 2011
Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome?Stephanie Madec, Chiara Rossi, Massimo Chiarugi, et al.
Acta Diabetologica|April 8, 2017
Determinants of glomerular filtration rate following bariatric surgery in individuals with severe, otherwise uncomplicated, obesity: an observational, prospective studyMarta Seghieri, Edoardo Vitolo, Livia Giannini, et al.
Diabetes/Metabolism Research and Reviews|January 22, 2026
Effect of SGLT2 Inhibitors + DPP-4 Inhibitors on Urine Microbiota in Type 2 DiabetesMarco Calvigioni, Edoardo Biancalana, Chiara Rossi, et al.
Oxidative Medicine and Cellular Longevity|December 23, 2017
Deficiency of the Purinergic Receptor 2X7 Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 InflammasomeClaudia Blasetti Fantauzzi, Stefano Menini, Carla Iacobini, et al.
The Journal of Clinical Endocrinology and Metabolism|November 22, 2018
Phthalates Exposure as Determinant of Albuminuria in Subjects With Type 2 Diabetes: A Cross-Sectional StudyAlessandro Mengozzi, Fabrizia Carli, Edoardo Biancalana, et al.
Cardiovascular Diabetology|October 25, 2017
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot studyAnna Solini, Livia Giannini, Marta Seghieri, et al.
Pageof 17